Statement by Mr. François Hollande, President of the Republic, on the right to be forgotten for individuals cured of cancer in matters of insurance and loans, in Paris on March 24, 2015.

France François Hollande · President of France

24 March 2015 · League, Paris, France

Context
Hollande addressed a ceremony at the League Against Cancer in Paris to announce the signing of the right to be forgotten protocol for cured cancer patients.
Main themes
Right to be forgotten for cancer survivors, insurance and loan access for former patients, AERAS agreement reform, medical progress in cancer treatment, patient rights, cancer plan 2014-2019, non-declaration principle, collective responsibility, France as international model
Duration
~12 min
41st percentile
Words
1,391
41st percentile
Sentences
66
43rd percentile
Readability
60
87th percentile
Grade
10.1
22nd percentile
Syntax
2.98
44th percentile
Vocabulary
1.95
5th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 77%77%
  • Ceremonial 12%12%
  • Institutional 6%6%
  • Economic 3%3%
  • Geopolitical 2%2%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

66 sentences in 17 paragraphs

Madam President, first of all, thank you for welcoming us here at the League for this truly exceptional ceremony, because it brings together ministers who will soon sign the texts, insurers, mutualists, associations, researchers, doctors, all those who want to fight against illness and at the same time grant rights to patients, especially former patients. This is the meaning of what we are going to proclaim today.

What we are dedicating through this event is progress, great progress. Progress that has been awaited for years by people who have been affected by cancer and who could not find the way to access their rights. They remained marked — that is the word you have used — throughout their lives not by the aftereffects of the illness but by the memory of the illness.

Many of these people had escaped the consequences of the illness but still could not free themselves from what the illness could have as administrative, financial, banking, and life insurance consequences.

This is progress that is also a symbol of advances in medicine, because today, let us say it, medicine cures cancers that were once considered fatal.

This progress has a name, it is a right: the right to be forgotten. The right to be forgotten is included in the third cancer plan that I personally presented for the period 2014/2019. This cancer plan, with this right to be forgotten, is subject to regular evaluation. I thank the president of INCA for her action. Today, we are indeed conducting a form of evaluation since the right to be forgotten is finally translated into reality.

How to state this right? It is indeed quite simple, so simple that it is very complicated to implement. Simple in its statement, it is about freeing former patients from the weight of the past and erasing all traces, I say all traces, of their illness from yesterday to allow them to apply for loans or simply to access property and to project themselves into the future. In short, to live fully.

This right, however, is not easy to implement. It has therefore required a whole struggle, a long process, a long approach that was initiated almost 25 years ago. It was in 1991 and it was the first agreement that dealt with the insurance of mortgage loans for seriously ill people. At that time, it concerned people living with HIV. It must be recognized that each time we fight against one illness, we also manage to fight against other illnesses. There is a link to be established between all patients or between all former patients.

Ten years later, the system was extended to all people presenting an aggravated health risk. We were therefore in 2001, but we had to wait until 2007 for a law to enshrine all these advances and allow access to insurance and loans with an aggravated health risk. But we were not yet in the right to be forgotten.

To bring the right to be forgotten into practice, that is to say also into legal reality, it remained to draw the consequences of medical progress, that is to say the healing of certain cancers. This considerable work has been carried out in recent months and I want to thank all those who contributed to it and made this advancement possible.

The protocol that is going to be signed will considerably broaden the scope of the AERAS agreement on which Mr. BELORGEY worked so hard. It will make the right to be forgotten the rule for cured cancers. The concrete implications are as follows: all people who had cancer before the age of 15 will no longer have anything to declare to their insurer five years after the end of their treatment. Similarly, the right to be forgotten will apply to all people who have had a cancerous pathology, 15 years after the end of treatment. This is what the president of INCA called the principle of non-declaration. And that changes everything. Until now, it was necessary to declare whether one was or was not. Now, there will be nothing to declare. And therefore nothing to ask of these people. Finally, when the period is less than 15 years, individuals will be able to be offered the normal rate for insurance based on a table, a table that will be published, an official table, a reference table updated according to advances in medicine. This means that if this update is done regularly, and it will be done regularly, the rates themselves will be modified accordingly since the risks themselves will have been reduced.

So it is a right to be forgotten for cured individuals, but it is also already a new right that is advanced, that is introduced for people still affected by the illness but whom we know will overcome the illness.

It is a unique system, on the international level, and there are times when France must set an example, and it is setting an example. The example, first of all, by the method that has been chosen, that of negotiation, which is mine.

It is certain that we could have introduced this mechanism by law, but I preferred that the bet of collective responsibility be launched to all stakeholders, that they seek an agreement among themselves, and this negotiation has succeeded. And I wanted to thank you for that.

It was not a bet won in advance, because evolving the AERAS agreement necessarily meant confronting different logics, different interests. First, there are the insurers, in all their diversity; there are also the administrations, the scientific communities, the patient associations, each pursuing their own objective. But here, this objective was called the general interest and the interest of patients. It was therefore necessary to bring to the table, I should say to multiple tables, the business leaders, the association activists, whom I salute, who are here, the scientists, the citizens, and your presence here is the demonstration that when there is will, France is capable of coming together around a great cause. There is no greater cause than that of the right to be forgotten for people who have been affected at some point in their lives, sometimes very young, by an illness. I am not just talking about cancer today.

This approach is also exemplary by the result obtained, because you had the wisdom to foresee that the agreement will evolve according to scientific knowledge, that the right will progress with medicine, that each time medicine advances, the law will also evolve. As we push back cancers and other serious illnesses, the law will advance even further. Tomorrow, the right to be forgotten will apply to all illnesses. What we have just decided here is to take a decisive step. This step, however, is not the last. I have heard from people, Madam President of the League, who came to talk to me about their current situation, still ill, soon to be cured, but still hindered in their access to loans, to property, sometimes even for their job retention.

We still have work to do. There is still much to change in behaviors and in prejudices regarding illnesses, and that is what we are doing here, also this morning: fighting against prejudices. It is hard work to fight against prejudices; there are prejudices everywhere. Those who use prejudices are often the most conservative, who are afraid of everything, except when they themselves are at some point affected by illness or difficulty. The right to be forgotten is ultimately also about forgetting prejudices. The right to be forgotten for former patients, yes, but also a message of hope for all those who have known or still know the ordeal of illness, but who have the hope, the infinite hope of being cured one day.

We thus show them first that the struggle, the struggle that is yours, the struggle for rights, the struggle for life, that this struggle can succeed. We guarantee them that once their illness is defeated, it will no longer haunt them. We commit to ensuring that they fully regain their place in society, in life. Finally, what we are doing today is to lay down with the right to be forgotten an act of solidarity, an act of trust in science, and an act of hope in the fight against all illnesses. Thank you.